Robert Koremans

Robert Koremans

Vorstandsvorsitzender bei RECORDATI
63 Jahre
Health Technology
Health Services
Process Industries

Profil

Robert Koremans currently works at Recordati SpA, as Chief Executive Officer & Director.
Dr. Koremans also formerly worked at Teva Pharmaceutical Industries Ltd., as President & CEO-Global Specialty Medicines from 2013 to 2017, Esperite NV, as Chief Executive Officer & Director from 2007 to 2009, Nutreco NV, as Chairman-Executive Board & Chief Executive Officer from 2019 to 2021, Zentiva Group as, as Chief Executive Officer from 2009 to 2011, Cryo-Save CZ sro, as Chief Executive Officer from 2007 to 2009, Teva Pharmaceuticals Europe BV, as President & Chief Executive Officer from 2012 to 2013, Grünenthal GmbH, as Director from 2007 to 2008, Sanofi, as Senior VP-Generics, Strategy & Development from 1988 to 1991, and Serono Corp., as Vice President-Europe, Middle East & Africa.
Dr. Koremans received his doctorate degree from Erasmus University Rotterdam.

Aktive Positionen von Robert Koremans

UnternehmenPositionBeginn
RECORDATI Vorstandsvorsitzender 01.12.2021
Private Equity Investor -

Ehemalige bekannte Positionen von Robert Koremans

UnternehmenPositionEnde
NUTRECO Vorstandsvorsitzender 15.08.2021
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 31.12.2017
Vorstandsvorsitzender 01.01.2013
Vorstandsvorsitzender 01.12.2011
Vorstandsvorsitzender 01.09.2009
Sehen Sie sich die Erfahrung von Robert Koremans im Detail an

Ausbildung von Robert Koremans

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

60

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Health Technology

Health Technology

Health Services

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Health Services

Miscellaneous

Serono Corp.

Finance

  1. Börse
  2. Insiders
  3. Robert Koremans
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT